Role of Diabetes Mellitus on Treatment Effects in Drug-susceptible Initial Pulmonary Tuberculosis Patients in China.
- Author:
Yan MA
1
,
2
,
3
;
Mai Ling HUANG
1
;
Tao LI
4
;
Jian DU
1
;
Wei SHU
1
;
Shi Heng XIE
1
;
Hong Hong WANG
1
;
Guo Feng ZHU
5
;
Shou Yong TAN
6
;
Yan Yong FU
7
;
Li Ping MA
8
;
Lian Ying ZHANG
9
;
Fei Ying LIU
10
;
Dai Yu HU
11
;
Yan Ling ZHANG
12
;
Xiang Qun LI
5
;
Yu Hong LIU
1
;
Liang LI
1
;
Author Information
- Publication Type:Journal Article
- Keywords: Diabetes mellitus; Treatment outcome; Tuberculosis
- MeSH: Antitubercular Agents; therapeutic use; China; epidemiology; Diabetes Mellitus; epidemiology; therapy; Female; Humans; Male; Mycobacterium tuberculosis; drug effects; Tuberculosis, Pulmonary; complications; drug therapy; epidemiology; microbiology
- From: Biomedical and Environmental Sciences 2017;30(9):671-675
- CountryChina
- Language:English
- Abstract: We assessed the role of diabetes mellitus (DM) on treatment effects in drug-susceptible initial pulmonary tuberculosis (PTB) patients. A prospective study was conducted in eight provinces of China from October 2008 to December 2010. We enrolled 1,313 confirmed drug-susceptible initial PTB patients, and all subjects received the treatment regimen (2H3R3E3Z3/4H3R3) as recommended by the national guidelines. Of the 1,313 PTB patients, 157 (11.9%) had DM; these patients had more sputum smear-positive rates at the end of the second month [adjusted odds ratios (aOR) 2.829, 95% confidence intervals (CI) 1.783-4.490], and higher treatment failure (aOR 2.120, 95% CI 1.565-3.477) and death rates (aOR 1.536, 95% CI 1.011-2.628). DM was a contributing factor for culture-positive rates at the end of the second month and treatment failure and death of PTB patients, thus playing an unfavorable role in treatment effects of PTB.